Update: 31.01.2023
Last week: 3 week 2023 (16.01.2023 - 22.01.2023)
Last full month: December 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 111 078 | -11.5% | 2.8% | -0.1 | 30 389 932 | -10.4% | 3.5% | 0 | -9.7% |
| MoM | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| YTD | 357 032 | -63.0% | 2.8% | -3.7 | 96 059 642 | -47.3% | 3.5% | -2.8 | -14.3% |
| MAT | 9 236 990 | -33.3% | 4.5% | -2 | 1 934 183 812 | -19.6% | 4.5% | -1.4 | -4.0% |
| DEXALGIN | |||||||||
| WoW | 20 409 | 2.0% | 0.4% | 0 | 10 804 741 | 3.1% | 1.4% | 0.1 | -0.8% |
| MoM | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| YTD | 58 591 | -56.5% | 0.4% | -0.4 | 30 958 945 | -40.8% | 1.4% | -1 | -9.3% |
| MAT | 1 509 470 | -19.7% | 0.6% | -0.1 | 665 321 304 | -7.3% | 1.6% | -0.3 | -1.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 58 831 | 9.0% | 41.4% | 1.7 | 38 730 154 | 6.9% | 52.6% | 0.4 | 4.5% |
| MoM | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| YTD | 153 144 | -52.6% | 40.3% | -21.4 | 99 725 493 | -35.4% | 51.5% | -16.9 | -27.5% |
| MAT | 4 113 925 | -22.7% | 51.9% | -13.8 | 2 153 991 639 | -12.4% | 57.9% | -12.4 | -2.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 322 | 8.4% | 29.7% | 2.4 | 16 949 263 | 10.3% | 47.4% | 3.8 | -0.5% |
| MoM | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| YTD | 59 894 | -35.8% | 29.4% | -10.2 | 46 541 793 | -15.4% | 46.1% | -8 | -13.5% |
| MAT | 1 392 706 | -15.9% | 36.4% | -4.8 | 897 080 821 | -7.5% | 49.9% | -6.1 | -4.8% |
| FASTUM | |||||||||
| WoW | 15 787 | -3.8% | 0.9% | 0 | 9 779 823 | -4.3% | 2.6% | -0.1 | 1.2% |
| MoM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| YTD | 46 275 | -46.4% | 1.0% | -0.6 | 28 520 434 | -29.7% | 2.7% | -0.9 | -11.0% |
| MAT | 1 000 578 | -27.9% | 1.1% | -0.4 | 534 332 902 | -17.1% | 2.4% | -0.7 | -0.9% |
| IODOMARIN | |||||||||
| WoW | 63 073 | 4.9% | 20.5% | 0 | 11 650 614 | 5.5% | 7.8% | 0 | 5.2% |
| MoM | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| YTD | 165 309 | -18.7% | 20.5% | -1.9 | 30 498 350 | -17.5% | 7.7% | -2.1 | -11.0% |
| MAT | 3 255 274 | 1.1% | 20.4% | -0.4 | 633 524 517 | 5.8% | 9.0% | -0.5 | 2.9% |
| LIOTON | |||||||||
| WoW | 13 385 | 6.4% | 1.5% | 0 | 16 548 452 | 8.0% | 3.7% | 0.2 | 4.7% |
| MoM | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| YTD | 36 437 | -54.0% | 1.4% | -1.2 | 44 267 733 | -36.3% | 3.6% | -2 | -16.0% |
| MAT | 1 208 896 | -28.8% | 2.2% | -0.6 | 1 282 178 017 | -9.4% | 4.5% | -1.1 | -8.4% |
| MEZYM | |||||||||
| WoW | 227 072 | -2.4% | 18.8% | -0.4 | 35 622 027 | -1.5% | 13.0% | -0.1 | -0.4% |
| MoM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| YTD | 684 921 | -52.8% | 19.7% | -12.2 | 105 888 242 | -47.9% | 13.5% | -10.1 | -23.5% |
| MAT | 16 584 672 | -21.3% | 24.7% | -4.7 | 2 546 758 581 | -13.9% | 17.5% | -4.4 | -6.3% |
| MIG 400 | |||||||||
| WoW | 119 804 | 6.1% | 2.4% | 0.2 | 15 220 214 | 2.7% | 2.0% | 0.1 | -0.8% |
| MoM | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| YTD | 334 116 | -37.9% | 2.4% | -1.1 | 43 011 058 | -30.5% | 2.0% | -0.9 | -9.3% |
| MAT | 8 192 092 | -18.7% | 3.1% | -0.7 | 975 301 737 | -14.4% | 2.4% | -0.7 | -1.3% |
| PROSTAMOL | |||||||||
| WoW | 22 698 | -2.6% | 14.1% | -0.5 | 34 239 663 | -3.9% | 16.1% | -0.6 | 0.6% |
| MoM | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| YTD | 62 329 | -48.3% | 14.1% | -9.8 | 93 315 429 | -41.0% | 16.0% | -9.6 | -12.7% |
| MAT | 1 488 203 | -30.2% | 17.6% | -6.9 | 2 099 991 422 | -22.3% | 18.8% | -7.8 | -2.7% |
| RESPERO MYRTOL | |||||||||
| WoW | 23 139 | -8.9% | 7.2% | -0.2 | 13 291 784 | -7.4% | 8.5% | -0.1 | -6.7% |
| MoM | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
| YTD | 70 662 | -27.2% | 7.4% | -2.1 | 39 993 085 | -5.7% | 8.6% | -0.5 | -6.3% |
| MAT | 1 275 135 | 53.1% | 8.2% | 2.6 | 621 160 565 | 62.5% | 8.4% | 2.7 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 357 032 | -63.0% | 2.8% | -3.7 | 96 059 642 | -47.3% | 3.5% | -2.8 | -14.3% |
| DEXALGIN | 58 591 | -56.5% | 0.4% | -0.4 | 30 958 945 | -40.8% | 1.4% | -1 | -9.3% |
| ESPUMISAN (ADULTS) | 153 144 | -52.6% | 40.3% | -21.4 | 99 725 493 | -35.4% | 51.5% | -16.9 | -27.5% |
| ESPUMISAN BABY | 59 894 | -35.8% | 29.4% | -10.2 | 46 541 793 | -15.4% | 46.1% | -8 | -13.5% |
| FASTUM | 46 275 | -46.4% | 1.0% | -0.6 | 28 520 434 | -29.7% | 2.7% | -0.9 | -11.0% |
| IODOMARIN | 165 309 | -18.7% | 20.5% | -1.9 | 30 498 350 | -17.5% | 7.7% | -2.1 | -11.0% |
| LIOTON | 36 437 | -54.0% | 1.4% | -1.2 | 44 267 733 | -36.3% | 3.6% | -2 | -16.0% |
| MEZYM | 684 921 | -52.8% | 19.7% | -12.2 | 105 888 242 | -47.9% | 13.5% | -10.1 | -23.5% |
| MIG 400 | 334 116 | -37.9% | 2.4% | -1.1 | 43 011 058 | -30.5% | 2.0% | -0.9 | -9.3% |
| PROSTAMOL | 62 329 | -48.3% | 14.1% | -9.8 | 93 315 429 | -41.0% | 16.0% | -9.6 | -12.7% |
| RESPERO MYRTOL | 70 662 | -27.2% | 7.4% | -2.1 | 39 993 085 | -5.7% | 8.6% | -0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 236 990 | -33.3% | 4.5% | -2 | 1 934 183 812 | -19.6% | 4.5% | -1.4 | -4.0% |
| DEXALGIN | 1 509 470 | -19.7% | 0.6% | -0.1 | 665 321 304 | -7.3% | 1.6% | -0.3 | -1.3% |
| ESPUMISAN (ADULTS) | 4 113 925 | -22.7% | 51.9% | -13.8 | 2 153 991 639 | -12.4% | 57.9% | -12.4 | -2.2% |
| ESPUMISAN BABY | 1 392 706 | -15.9% | 36.4% | -4.8 | 897 080 821 | -7.5% | 49.9% | -6.1 | -4.8% |
| FASTUM | 1 000 578 | -27.9% | 1.1% | -0.4 | 534 332 902 | -17.1% | 2.4% | -0.7 | -0.9% |
| IODOMARIN | 3 255 274 | 1.1% | 20.4% | -0.4 | 633 524 517 | 5.8% | 9.0% | -0.5 | 2.9% |
| LIOTON | 1 208 896 | -28.8% | 2.2% | -0.6 | 1 282 178 017 | -9.4% | 4.5% | -1.1 | -8.4% |
| MEZYM | 16 584 672 | -21.3% | 24.7% | -4.7 | 2 546 758 581 | -13.9% | 17.5% | -4.4 | -6.3% |
| MIG 400 | 8 192 092 | -18.7% | 3.1% | -0.7 | 975 301 737 | -14.4% | 2.4% | -0.7 | -1.3% |
| PROSTAMOL | 1 488 203 | -30.2% | 17.6% | -6.9 | 2 099 991 422 | -22.3% | 18.8% | -7.8 | -2.7% |
| RESPERO MYRTOL | 1 275 135 | 53.1% | 8.2% | 2.6 | 621 160 565 | 62.5% | 8.4% | 2.7 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 111 078 | -11.5% | 2.8% | -0.1 | 30 389 932 | -10.4% | 3.5% | 0 | -9.7% |
| DEXALGIN | 20 409 | 2.0% | 0.4% | 0 | 10 804 741 | 3.1% | 1.4% | 0.1 | -0.8% |
| ESPUMISAN (ADULTS) | 58 831 | 9.0% | 41.4% | 1.7 | 38 730 154 | 6.9% | 52.6% | 0.4 | 4.5% |
| ESPUMISAN BABY | 21 322 | 8.4% | 29.7% | 2.4 | 16 949 263 | 10.3% | 47.4% | 3.8 | -0.5% |
| FASTUM | 15 787 | -3.8% | 0.9% | 0 | 9 779 823 | -4.3% | 2.6% | -0.1 | 1.2% |
| IODOMARIN | 63 073 | 4.9% | 20.5% | 0 | 11 650 614 | 5.5% | 7.8% | 0 | 5.2% |
| LIOTON | 13 385 | 6.4% | 1.5% | 0 | 16 548 452 | 8.0% | 3.7% | 0.2 | 4.7% |
| MEZYM | 227 072 | -2.4% | 18.8% | -0.4 | 35 622 027 | -1.5% | 13.0% | -0.1 | -0.4% |
| MIG 400 | 119 804 | 6.1% | 2.4% | 0.2 | 15 220 214 | 2.7% | 2.0% | 0.1 | -0.8% |
| PROSTAMOL | 22 698 | -2.6% | 14.1% | -0.5 | 34 239 663 | -3.9% | 16.1% | -0.6 | 0.6% |
| RESPERO MYRTOL | 23 139 | -8.9% | 7.2% | -0.2 | 13 291 784 | -7.4% | 8.5% | -0.1 | -6.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| DEXALGIN | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| ESPUMISAN (ADULTS) | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| ESPUMISAN BABY | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| FASTUM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| IODOMARIN | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| LIOTON | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| MEZYM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| MIG 400 | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| PROSTAMOL | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| RESPERO MYRTOL | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs